Cyteir Therapeutics, Inc. (CYT) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is neutral — 2 Buy, 1 Hold, 2 Sell.
The consensus price target is $2.00, representing a downside of 33.8% from the current price $3.02.
CYT Stock — 12-Month Price Forecast
$2.00
▼ -33.77% Downside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Cyteir Therapeutics, Inc., the price target is $2.00.
The average price target represents a -33.77% change from the last price of $3.02.
CYT Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Cyteir Therapeutics, Inc. in the past 3 months
